Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. WuXi AppTec Co., Ltd.
  6. News
  7. Summary
    603259   CNE1000031K4

WUXI APPTEC CO., LTD.

(603259)
  Report
End-of-day quote Shanghai Stock Exchange  -  2022-08-17
90.79 CNY   -1.25%
08/15WuXi ATU Announces Licensing Agreement with Janssen for TESSA Technology
AQ
08/09DELIVERING ON THE PROMISE OF NEW THERAPIES FOR RARE DISEASES : An Interview with Ralph Laufer, CSO of Lysogene
PU
08/01DELIVERING THE PROMISE OF NEW MODALITIES : An Interview with Mark Frohlich, CEO, Indapta Therapeutics
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about WUXI APPTEC CO., LTD.
08/15WuXi ATU Announces Licensing Agreement with Janssen for TESSA Technology
AQ
08/09DELIVERING ON THE PROMISE OF NEW THE : An Interview with Ralph Laufer, CSO of Lysogene
PU
08/01DELIVERING THE PROMISE OF NEW MODALI : An Interview with Mark Frohlich, CEO, Indapta Thera..
PU
07/29UBS Adjusts Wuxi Apptec's Price Target to HK$175 From HK$173, Keeps at Buy
MT
07/27WUXI APPTEC : DDSU - 2022 Investor Day
PU
07/27WUXI APPTEC : ATU - 2022 Investor Day
PU
07/27WUXI APPTEC : Biology - 2022 Investor Day
PU
07/27WUXI APPTEC : Testing - 2022 Investor Day
PU
07/27WUXI APPTEC : Chemistry - 2022 Investor Day
PU
07/27WUXI APPTEC : Industry Trend and Company Strategy - 2022 Investor Day
PU
07/27WUXI APPTEC : Financial Performance - 2022 Investor Day
PU
07/27Nomura Adjusts Wuxi Apptec's Price Target to HK$171.11 From HK$181.12, Keeps at Buy
MT
07/27Nomura Adjusts Wuxi Apptec's Price Target to 147.15 Yuan From 148.52 Yuan, Keeps at Buy
MT
07/26WuXi AppTec's H1 Profit Jumps 73%; Shares Fall 4% in Shanghai
MT
07/26WUXI APPTEC : 2022 Interim Results Presentation
PU
More most relevant news
All news about WUXI APPTEC CO., LTD.
08/15WuXi ATU Announces Licensing Agreement with Janssen for TESSA Technology
AQ
08/09DELIVERING ON THE PROMISE OF NEW THE : An Interview with Ralph Laufer, CSO of Lysogene
PU
08/01DELIVERING THE PROMISE OF NEW MODALI : An Interview with Mark Frohlich, CEO, Indapta Thera..
PU
07/29UBS Adjusts Wuxi Apptec's Price Target to HK$175 From HK$173, Keeps at Buy
MT
07/27WUXI APPTEC : DDSU - 2022 Investor Day
PU
07/27WUXI APPTEC : ATU - 2022 Investor Day
PU
07/27WUXI APPTEC : Biology - 2022 Investor Day
PU
07/27WUXI APPTEC : Testing - 2022 Investor Day
PU
07/27WUXI APPTEC : Chemistry - 2022 Investor Day
PU
07/27WUXI APPTEC : Industry Trend and Company Strategy - 2022 Investor Day
PU
More news
News in other languages on WUXI APPTEC CO., LTD.
07/29Las acciones chinas caen; los beneficios podrían impulsar el mercado en agosto -- Marke..
07/26Le bénéfice de WuXi AppTec au premier semestre fait un bond de 73 % ; les actions chute..
07/26WuXi AppTec Co., Ltd. annonce ses résultats pour le semestre clos le 30 juin 2022
07/26WuXi AppTec Co., Ltd. fournit des prévisions de revenus pour l'année 2022
07/22Wuxi Apptec réalise 2,6 millions de dollars de recettes au premier semestre
07/22Les entreprises chinoises Wuxi AppTec et Wuxi Biologics vont investir chacune 1,4 milli..
07/19WuXi AppTec prévoit de construire un nouveau site de R&D et de fabrication à Singapour
07/12Sirona Biochem annonce le début de l'essai clinique d'un composé anti-vieillissement et..
07/12WuXi AppTec enregistre une hausse de son bénéfice et de son chiffre d'affaires au premi..
06/22Sirona Biochem confie à WuXi AppTec la fabrication d'un composé anti-âge destiné à un e..
More news
Analyst Recommendations on WUXI APPTEC CO., LTD.
07/29UBS Adjusts Wuxi Apptec's Price Target to HK$175 From HK$173, Keeps at Buy
MT
07/27Nomura Adjusts Wuxi Apptec's Price Target to HK$171.11 From HK$181.12, Keeps at Buy
MT
07/27Nomura Adjusts Wuxi Apptec's Price Target to 147.15 Yuan From 148.52 Yuan, Keeps at Buy
MT
04/28UBS Adjusts WuXi AppTec's Price Target to HK$173 From HK$192, Keeps at Buy
MT
02/17Nomura Adjusts Wuxi Apptec's Price Target to HK$181.12 From HK$208.86, Keeps at Buy
MT
More recommendations
Press releases
08/15WuXi ATU Announces Licensing Agreement with Janssen for TESSA Technology
AQ
08/09DELIVERING ON THE PROMISE OF NEW THE : An Interview with Ralph Laufer, CSO of Lysogene
PU
08/01DELIVERING THE PROMISE OF NEW MODALI : An Interview with Mark Frohlich, CEO, Indapta Thera..
PU
07/27WUXI APPTEC : DDSU - 2022 Investor Day
PU
07/27WUXI APPTEC : ATU - 2022 Investor Day
PU
More press releases
Official Publications
2020Press Release 
20203rd quarter report 
2020Press Release 
2020Half-year results 
2020Half-year report 
20201st quarter report 
Upcoming event on WUXI APPTEC CO., LTD.
11/03/22Q3 2022 Earnings Release (Projected)
Upcoming sector events
10/27/22GILEAD SCIENCES, INC. : Q3 2022 Earnings Release (Projected)
11/02/22VERTEX PHARMACEUTICALS INCORPORATED : Q3 2022 Earnings Release (Projected)
11/07/22BIONTECH SE : Q3 2022 Earnings Release
11/08/22REGENERON PHARMACEUTICALS, INC. : Q3 2022 Earnings Release (Projected)
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs